Unpacking pDNA Processes: Capacity, Complexity, And Cutting-Edge Solutions

As gene therapies, mRNA vaccines, and cell therapies drive unprecedented demand for plasmid DNA (pDNA), manufacturers are under pressure to scale production quickly and efficiently. Yet, expanding capacity isn’t as simple as adding more equipment. Unexpected challenges in facility design, process development, and regulatory readiness can derail timelines and budgets. In this expert-led panel, leaders from Bionova, Cytiva, and other innovators share insights into the evolving pDNA landscape. Learn how flexible, modular facilities and emerging technologies in fermentation, purification, and analytics are reshaping the path to GMP readiness. The discussion also highlights common missteps in capacity planning and offers practical strategies to avoid them.

Whether you're entering the pDNA space or preparing for scale-up, discover actionable guidance to help you meet therapeutic demand and position your operations for clinical and commercial success.